Search Results

You are looking at 81 - 90 of 231 items for :

  • prognostic factor x
  • Refine by Access: All content x
Clear All
Open access

Anne M Drewes, Maria E Møller, Rasmus Hertzum-Larsen, Gerda Engholm, and Hans H Storm

-term follow-up allows us to study common risk factors and consequences of the treatment. Schoenberg in 1975 ( 1 ) and Helseth in 1989 ( 2 ) already demonstrated an increased risk of meningioma in breast cancer patients from Connecticut and Norway, respectively

Open access

Sondra O’Callaghan and Hanford Yau

confirm that MAH portends a poor prognosis ( 8 ). In fact, a bedside prognostic score has been developed and used in studies evaluating hypercalcemia as an independent prognostic factor ( 9 , 15 ). Certainly, newer targeted anti-cancer therapies may

Open access

Sofia S Pereira, Mariana P Monteiro, Sonir R Antonini, and Duarte Pignatelli

Libe R Borget I Ronchi CL Zaggia B Kroiss M Kerkhofs T Bertherat J Volante M Quinkler M Chabre O , Prognostic factors in stage III–IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study . Annals of

Open access

Hugo R Ramos, Andreas L Birkenfeld, and Adolfo J de Bold

not correlate with hemodynamic variables but correlate with the levels of regulated on activation, normal T expressed and secreted, insulin growth factor binding protein-1 and neutrophil activating protein-2 (4) . In non-rejecting transplanted

Open access

Mette Faurholdt Gude, Rikke Hjortebjerg, Mette Bjerre, Morten Haaning Charles, Daniel R Witte, Annelli Sandbæk, and Jan Frystyk

likely related to its ability to increase insulin-like growth factor-1 (IGF1) action. PAPP-A activates IGF1 through proteolytic cleavage of IGF-binding proteins (IGFBP) -2, -4 and -5, which provides IGFBP fragments with low ligand affinity. By this

Open access

Tiina Vesterinen, Teijo Kuopio, Maarit Ahtiainen, Aija Knuuttila, Harri Mustonen, Kaisa Salmenkivi, Johanna Arola, and Caj Haglund

toward poorer overall survival and progression-free survival, although statistical significance was not reached in their study either ( 21 ). Fan et al . reported PD-L1 expression in cancer cells to be an independent favorable prognostic factor ( 16

Open access

Anello Marcello Poma, Riccardo Giannini, Paolo Piaggi, Clara Ugolini, Gabriele Materazzi, Paolo Miccoli, Paolo Vitti, and Fulvio Basolo

lobectomy may be a sufficient treatment for low-risk FTC (i.e. MI-FTC with less than 4 vascular invasion foci) ( 12 ). However, molecular markers such as TERT promoter mutations were found to be an independent poor prognosis factor in differentiated

Open access

Katherine Van Loon, Li Zhang, Jennifer Keiser, Cendy Carrasco, Katherine Glass, Maria-Teresa Ramirez, Sarah Bobiak, Eric K Nakakura, Alan P Venook, Manisha H Shah, and Emily K Bergsland

practices, surveillance guidelines, and design of clinical trials (9) . This study pooled data from two NCI-designated Comprehensive Cancer Centers with the aim of reporting the natural history of and prognostic factors associated with bone metastases from

Open access

Erika Urbano Lima, Ileana G S Rubio, Joaquim Custodio Da Silva, Ana Luiza Galrão, Danielle Pêssoa, Taise Cerqueira Oliveira, Fabiane Carrijo, Igor Silva Campos, Luciano Fonseca Espinheira, Luiz Jose Sampaio, Claudio Rogerio Lima, Janete Maria Cerutti, and Helton Estrela Ramos

.008) and older age ( P  = 0.006) ( Fig. 7 ). Multivariate Cox analysis with BRAF status and variables that correlates with worse prognosis and univariate analysis showed that hyper-methylation was an independent prognostic factor for worse prognosis ( P

Open access

S C Clement, W E Visser, C A Lebbink, D Albano, H L Claahsen-van der Grinten, A Czarniecka, R P Dias, M P Dierselhuis, I Dzivite-Krisane, R Elisei, A Garcia-Burillo, L Izatt, C Kanaka-Gantenbein, H Krude, L Lamartina, K Lorenz, M Luster, R Navardauskaitė, M Negre Busó, K Newbold, R P Peeters, G Pellegriti, A Piccardo, A L Priego, A Redlich, L de Sanctis, M Sobrinho-Simões, A S P van Trotsenburg, F A Verburg, M Vriens, T P Links, S F Ahmed, and H M van Santen

Redlich A Luster M Lorenz K Lessel L Rohrer TR Schmid KW Frühwald MC Vorwerk P Kuhlen M . Age, American Thyroid Association Risk Group, and Response to Therapy Are Prognostic Factors in Children With Differentiated Thyroid Cancer